Confirmed Speakers/ Chairpersons/ Moderators

List of Confirmed Speakers/ Chairpersons/ Moderators *

1. Dr Matti Aapro, Dean, Multidisciplinary Oncology Institute, Clinique de Genolier, SWITZERLAND
2. Prof Janet L. Abrahm, Associate Professor Of Medicine And Anesthesia, Dana Farber Cancer Center, Harvard University, USA
3. Prof René Adam, Department of Surgery, Paul - Brousse Hospital, FRANCE
4. Dr Costas G Alexopoulos, MD(Ath), MRCP(UK), FRCP(Lon), Consultant Medical Oncologist, Iatriko Medical Centre, GREECE
5. Dr Fabrice André, MD, PhD, Institut Gustave Roussy, FRANCE
6. Prof Mickael Aoun, Institute Jules Bordet, BELGIUM
7. Prof Deborah Armstrong, Associate Professor of Oncology, Associate Professor of Gynecology and Obstetrics, Johns Hopkins Kimmel Cancer Center, USA
8. Prof Dirk Arnold, MD, Associate Professor, Department of Medical Oncology and Haematology, Martin Luther University, University Hospital, GERMANY
9. Dr Athanasios Athanasiou, Consultant Medical Oncologist, Metaxa Cancer Hospital of Piraeus, GREECE
10. Prof Aristotle Bamias, Assistant Professor, Department of Clinical Therapeutics, Medical School, National & Kapodistrian University of Athens, GREECE
11. Dr Vassilis Barbounis, Director of Oncology Unit “Ippokratio” Athens General Hospital, GREECE
12. Dr Ion Bellenis, Consultant Thoracic Surgeon, Evangelismos Hospital, GREECE
13. Prof Francesco Bertoni, Oncology Institute of Southern Switzerland, Editor-In-Chief, Hematological Oncology Journal, SWITZERLAND
14. Dr Axel Bex, Department of Urology Division of Surgical Oncology, The Netherlands Cancer Institute, THE NETHERLANDS
15. Dr James Brennan, Consultant Clinical Psychologist/ Honorary Senior Lecturer in Palliative Medicine, Bristol Haematology & Oncology Centre / University of Bristol, UK
16. Silvia Camporesi, Associate Editor, Ecancer Medical Science, ITALY
17. Prof Wendy Chen, MD MPH, Assistant Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School, USA
18. Pier Franco Conte, Professor of Oncology, Director of Division of Medical Oncology, University of Modena and Reggio Emilia, ITALY
19. Prof Finbarr E. Cotter, Head of Experimental Haematology, Department of Medical Oncology, Barts and London School of Medicine, Editor-in-Chief, British Journal of Haematology, UK
20. Prof David E. Crawford, Professor of Surgery, Urology, & Radiation Oncology, University of Colorado, USA
21. Prof Michael Cullen, Consultant and Honorary Professor of Medical Oncology, Cancer Centre, Oncology - University Hospitals Birmingham NHS Foundation Trust, UK
22. Dr Giuseppe Curigliano, Senior Deputy Director, Division of Medical Oncology, European Institute of Oncology, ITALY
23. Dr John Davis, MD, Assistant Professor, The University of Texas, MD Anderson Cancer Center, USA
24. Dr Thierry de Baére, MD, Head of Interventional Radiology Department, Institute Gustave Roussy, FRANCE
25. Dr Aimery de Gramont, Head of Oncology Department, Hospital St Antoine, FRANCE
26. Prof Madhav V. Dhodapkar, Professor of Medicine, Chief, Section of Hematology, Department of Internal Medicine. Director of Hematologic Malignancies, Yale Cancer Center, USA
27. Prof Volker Diehl, Professor of Medicine, University of Cologne, GERMANY
28. Prof Anna Efremidis, Ass. Professor – Director, Medical Oncology Department, Anticancer Hospital of Athens”Agios Savvas”, GREECE
29. Prof Alexander M.M. Eggermont, Professor and Head Surgical Oncology, Erasmus University Mc – Daniel Den Hoed Cancer Center, THE NETHERLANDS
30. Prof Tim Eisen, Department of Oncology University of Cambridge, Addenbrooke’s Hospital, UK
31. Dr Keith Flaherty, Director of Developmental Therapeutics, Massachusetts General Hospital Cancer Center, Editorial Board, Pigment Cell & Melanoma Research, USA
32. Dr Sara Gandini, Staff Scientist, European Institute of Oncology, ITALY
33. Prof Christos Georgiades, MD PhD, Associate Professor of Radiology & Surgery, Clinical Director, Department of Vascular & Interventional Radiology, Johns Hopkins Hospital, USA
34. Prof Jean-Francois Geschwind, MD, Professor of Radiology, Surgery & Oncology, Chief, Department of Vascular & Interventional Radiology, Johns Hopkins Hospital, USA
35. Prof Helen Gogas, Ass. Professor of Medical Oncology, 1st Department of Medicine, Medical School, University of Athens, GREECE
36. Prof Peter Goldstraw, Professor οf Thoracic Surgery, Imperial College London, Consultant Thoracic Surgeon, Royal Brompton Hospital, UK
37. Prof Mary Gospodarowicz, Professor and Chair, Department of Radiation Oncology, University of Toronto, Regional Vice-President Cancer Care Ontario, Toronto, Medical Director, Cancer Program and Chief, Radiation Medicine Program, Princess Margaret Hospital, University Health Network, CANADA
38.  Dr Frank Greco, MD, Director, Sarah Cannon Cancer Center, Tennessee Oncology, USA
39. Prof Thomas Gruenberger, Head, HB-Service, Department of General Surgery, Medical University Vienna, AUSTRIA
40. Dr John D. Hainsworth, Chief Scientific Officer, Sarah Cannon Research Institute, USA
41. Dr Kevin Joseph Harrington, Senior Lecturer and Honorary Consultant in Clinical Oncology, Head and Neck Unit, Gynaecological Oncology Unit and Melanoma Unit, Royal Marsden Hospital, UK
42. Prof Alan Horwich, Professor of Radiotherapy, Institute of Cancer Research, UK
43. Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital, UK
44. Prof Thomas Kieber-Emmons, Professor of Pathology, University of Arkansas for Medical Sciences, Deputy Director, Winthrop P. Rockefeller Cancer Institute, USA
45. Prof Jean Klastersky, Professor of Medicine, Université Libre de Bruxelles, BELGIUM
46. Dr Katerina Kotsori, Clinical Fellow, Breast Unit, Royal Marsden Hospital, UK
47. Prof Deborah Kuban, MD, Professor, The University of Texas, M. D. Anderson Cancer Center, USA
48. Prof Thierry Le Chevalier, Department of Medicine, Institute Gustave Roussy, FRANCE
49. Prof Jonathan Ledermann, Director & Professor of Medical Oncology, UCL Cancer Research UK Centre, UK
50. Prof Riccardo Lencioni, University Professor, Director, Division of Diagnostic Imaging and Intervention, University of Pisa School of Medicine, ITALY
51. Prof Dr Peter Lichter, Head of Division, Chief Editor, German Cancer Research Center, Division of Molecular Genetics, International Journal of Cancer, GERMANY
52. Dr Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital, Senior Lecturer, National Heart and Lung Institute, Imperial College, UK
53. Prof Christopher J. Logothetis, Professor, Chairman, Department of Genitourinary Medical Oncology, The University of Texas, MD Anderson Cancer Center, USA
54. Dr Fergus Macbeth, Director of the Centre for Clinical Practice, National Institute for Health and Clinical Excellence (NICE), UK
55. Dr Iain C. Macdougall, Consultant Nephrologist, Department of Renal Medicine, Kings College Hospital, UK
56. Prof Patrick Mantyh, University of Arizona, USA
57. Prof John L. Marshall, Professor, Chief of Hematological Oncology, Georgetown University, USA
58. Prof Shahla Masood, Professor and Chair, Department of Pathology, University of Florida College of Medicine, Jacksonville, USA
59. Dr Athena Matakidou, CRUK Clinician Scientist Fellow Tumour Modelling and Cancer Medicine Laboratory CRUK Cambridge Research Institute UK
60. Prof J. Gordon Mcvie, MD, FRCP, FRCS Ed, FMedSci, DSc(Hon), Senior Consultant, Scientific Directorate, European Institute of Oncology, ITALY
61. Dr Gary Middleton, Consultant Medical Oncologist, Royal Surrey County Hospital, UK
62. Dr David Miles, Miles Mount Vernon Hospital, UK
63. Prof Kurt Miller, Department of Urology, Charité Berlin, GERMANY
64. Ms Clare Moynihan, Senior Research Fellow, Medical Sociologist, The Institute of Cancer Research and The Royal Marsden Hospital Foundation Trust (honorary position), UK
65. Raj Naik, Consultant and Clinical Director, Northern Gynaecological Oncology Centre, Gateshead, UK
66. Prof Dr Carsten Nieder, Professor, Head of the Radiation Oncology Programme, Department of Oncology, Nordland Hospital, NORWAY
67. Prof Dr Hans W Nijman, MD, PhD, Professor of Gynaecologic Oncology & Immunotherapy, Department Of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, THE NETHERLANDS
68. Prof Marianna Nuti, University Full Professor, Department of Experimental Medicine, University of Rome Sapienza, ITALY
69. Dr Chris Nutting, BSc FRCP FRCR MD, Consultant and Reader in Clinical Oncology, Director of Head and Neck Unit, The Royal Marsden NHS Foundation Trust, UK
70. Dr Jens Overgaard, Department of Experimental Clinical Oncology, Aarhus University Hospital, DENMARK
71. Prof Lars Påhlman, Professor, Uppsala University,  SWEDEN
72. Prof Demetris Papamichael, Consultant in Medical Oncology, Director, Department of Medical Oncology, Bank of Cyprus Oncology Centre, CYPRUS
73. Prof George Pentheroudakis, Assistant Professor in Oncology, Medical School, University of Ioannina, GREECE
74. Dr Christophe Pomel, Centre Jean Perrin, FRANCE
75. Dr Sanjay Popat, Clinical Senior Lecturer and Consultant Medical Oncologist, Imperial College and The Royal Marsden Hospital, UK
76. Prof Eric Pujade – Lauraine, Head of Medical Oncology, Department Hôpital Hotel-Dieu, FRANCE
77. Prof Kenneth V. Rolston, The University of Texas, MD Anderson Cancer Center, USA
78. Prof Philippe Rougier, Hospital Ambroise Pare, FRANCE
79. Prof George Samonis, Professor Of Medicine, Medical Oncologist - Infectious Diseases Specialist, Medical School, The University Of Crete, GREECE
80. Prof Fritz H. Schröder, Professor of Urology, Erasmus Medical Center, THE NETHERLANDS
81. Prof Ben Slotman, Department of Radiation Oncology, VU University Medical Center, THE NETHERLANDS
82. Prof Kjetil Søreide, Associate Professor of Surgery, Surgeon, Stavanger University Hospital, Editor, British Journal of Surgery, NORWAY
83. Prof Nick Spirtos, Professor, The University Of Nevada School Of Medicine, Director Of The Division Of Gynecologic Oncology, Women's Cancer Center Of Nevada, USA
84. Prof Nick Stathakis, University of Thessaly, GREECE
85. Dr George Stathopoulos, Medical Oncology Department, Henry Dunant Hospital, GREECE
86. Dr Astrid T. Stormorken, Locum Consultant, The Royal Marsden Hospital, London, UK
87. Prof Jeffrey Tobias, Professor, University College London, Co-Editor, Cancer & its Management, UK
88. Dr William D. Travis, Attending Thoracic Pathologist, Department Of Pathology, Memorial Sloan Kettering Cancer Center, USA
89. Dr Nicholas Turner, Senior Lecturer and Honorary Consultant in Medical Oncology, Breakthrough Breast Cancer Research Centre and Royal Marsden Hospital, UK
90. Prof Dr Jan Van Meerbeek, Professor in Thoracic Oncology, Ghent University Hospital,  BELGIUM
91. Dr Gauri Varadhachary, MD, University of Texas,  M.D. Anderson Cancer Center, USA
92. Dr Charles J. Vecht, Neuro-Oncologist, Medical Centre The Hague, THE NETHERLANDS
93. Prof Jamie Von Roenn, MD, Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, The Feinberg School of Medicine, The Robert H Lurie Comprehensive Cancer Center, Northwestern University, USA
94. Prof Heather Wakelee, Assistant Professor, Department of Medicine, Stanford Comprehensive Cancer Centre, USA
95. Prof Maggie Watson, Head Of Service, Royal Marsden Hospital, UK
96. Prof Dr Michael Weller, Department of Neurology, University Hospital Zurich, SWITZERLAND
97. Prof Bertram Wiedenmann, Head of Department, Charite - Universitatsmedizin Berlin, Campus Kirchow Klinikum, Medizinische Klinik M. S. Hepatologie Und Gastroenterologie, GERMANY
98. Dr Peer Wille-Jørgensen, Consultant Surgeon, Department of Surgery K, Bisperbjerg Hospital, DENMARK
99. Dr Norman Wolmark, Chairman, NSABP (National Surgical Adjuvant Breast and Bowel Project), USA
100. Prof Nikos Zamboglou, Professor of Oncology, Director Haematology Oncology, Albert Ludwigs University of Freiburg, Adult Oncologist, Klinikum Offenbach GmbH, GERMANY

* as of September 2nd, 2010